Year 2016 -
June 29, 2016
IPA Meeting with the FDA: Quality Forum Update, Washington DC.
May 13, 2016
Presentation to IGDRP: Licensing of Generic Products: Needs and Expectation of Industry, Strasbourg.
January 29, 2021
IPA Submission – USTR Special 301 Report
January 25, 2021
IPA Employee Safety Initiatives Report
March 28, 2021
Patient-centricity must drive the pharma sector
March 25, 2021
PCI introduces faculty-industry training programme for teachers to make students industry-ready after graduation
March 22, 2021
Teachers should have good knowledge of drug development through exposure to industry practices: Expert
March 19, 2021
Dr Reddy’s On Digitization Amid COVID-19, ‘Lights-Out’ Manufacturing
March 18, 2021
Underlying the challenges and opportunities
March 1, 2021
Pharma stalwarts demystify COVID-19 impact on industry
February 25, 2021
Realisation there in pharma industry to become self-reliant in API production: IPA
February 22, 2021
India Pharmaceutical Forum to focus on patients, Covid-19
February 18, 2021
Pharma is a jewel in India’s crown with long term growth opportunities
January 28, 2021
Innovation and collaboration will help Indian pharma leapfrog in the global value chain: Experts
January 25, 2021
Back to Growth: Pharmaceutical sector overview and interview with Sudarshan Jain, Secretary General, IPA
January 24, 2021
Union Budget 2021: Covid-19 pandemic underlines need for higher allocation for healthcare sector
January 23, 2021
Industry opens bag of expectations for Union Budget 2021-22
January 20, 2021
Drug manufacturers hope new US govt will see them as ‘allies’
